Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
Journal of the American College of Cardiology · 2025-04 · 85 (15) · 1550-1564
DOI: 10.1016/j.jacc.2025.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2025-04. Verfasst von Margret Leosdottir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Skåne University Hospital, Malmö, Sweden; Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Electronic…. Hauptthemen laut MEDLINE: Ezetimibe, Myocardial Infarction, Registries, Anticholesteremic Agents. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lunds Universitet, Region Skåne, Swedish Heart and Lung Association.
Abstract (Originalsprache)
BACKGROUND: Combination lipid-lowering therapy (LLT) after myocardial infarction (MI) achieves lower low-density lipoprotein cholesterol (LDL-C) levels and better cardiovascular outcomes vs statin monotherapy. As a result, global guidelines recommend lower LDL-C but, paradoxically, advise treatment through a stepwise approach. Yet the need for combination therapy is inevitable as
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Skåne University Hospital, Malmö, Sweden; Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Electronic address: margret.leosdottir@med.lu.se.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, London, United Kingdom; Department of Internal Medicine, University…
- Sence Research, Uppsala, Sweden.
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
- Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, London, United Kingdom; Imperial Clinical Trials Unit, Imperial Coll…
Förderung
- Lunds Universitet
- Region Skåne
- Swedish Heart and Lung Association
- NIHR Imperial Biomedical Research Centre
- Region Uppsala
- Uppsala Universitet
Zitieren
APA
Leosdottir, M., Schubert, J., Brandts, J., Gustafsson, S., Cars, T., Sundström, J., Jernberg, T., Ray, K. K., & Hagström, E. (2025). Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry. Journal of the American College of Cardiology, 85(15), 1550-1564. https://doi.org/10.1016/j.jacc.2025.02.007
Vancouver
Leosdottir M, Schubert J, Brandts J, Gustafsson S, Cars T, Sundström J, et al. Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry. Journal of the American College of Cardiology. 2025;85(15):1550-1564. doi:10.1016/j.jacc.2025.02.007
BibTeX
@article{Leosdottir2025,
author = {Leosdottir, Margret and Schubert, Jessica and Brandts, Julia and Gustafsson, Stefan and Cars, Thomas and Sundström, Johan and Jernberg, Tomas and Ray, Kausik K and Hagström, Emil},
title = {Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry},
journal = {Journal of the American College of Cardiology},
year = {2025},
volume = {85},
number = {15},
pages = {1550--1564},
doi = {10.1016/j.jacc.2025.02.007}
}
EUVIMED